Data_Sheet_1_Comparative Efficacies of Linezolid vs. Tedizolid in an Experimental Murine Model of Vancomycin-Resistant Enterococcal (VRE) Bacteremia.docx (14.88 kB)
Download fileData_Sheet_1_Comparative Efficacies of Linezolid vs. Tedizolid in an Experimental Murine Model of Vancomycin-Resistant Enterococcal (VRE) Bacteremia.docx
dataset
posted on 2019-02-20, 04:02 authored by Wessam Abdelhady, Nagendra N. MishraTedizolid (TZD) is an oxazolidinone derivative which demonstrates bacteriostatic activity through inhibition of protein synthesis. We compared the efficacies of TZD and an earlier-generation oxazolidinone, linezolid (LZD), in an experimental murine model of bacteremia caused by two VRE strains (one each E. faecium and E. faecalis). LZD exhibited significantly better efficacy in terms of reduced VRE blood and target tissue densities than TZD in this model.
History
References
- https://doi.org//10.1016/j.diagmicrobio.2014.08.011
- https://doi.org//10.1371/journal.pone.0043958
- https://doi.org//10.12688/f1000research.11831.1
- https://doi.org//10.1056/NEJMoa1011138
- https://doi.org//10.1007/s00284-018-1491-3
- https://doi.org//10.1093/cid/cit615
- https://doi.org//10.1080/00498250210158249
- https://doi.org//10.1086/338514
- https://doi.org//10.1371/journal.pone.0071151
- https://doi.org//10.1128/AAC.00346-12
- https://doi.org//10.1128/AAC.06427-11
- https://doi.org//10.1128/AAC.05354-11
- https://doi.org//10.1128/AAC.00880-16
- https://doi.org//10.1093/femsle/fnx284
Usage metrics
Read the peer-reviewed publication
Categories
- Radiology and Organ Imaging
- Foetal Development and Medicine
- Obstetrics and Gynaecology
- Medical Genetics (excl. Cancer Genetics)
- Medical and Health Sciences not elsewhere classified
- Dermatology
- Emergency Medicine
- Gastroenterology and Hepatology
- Geriatrics and Gerontology
- Intensive Care
- Primary Health Care
- Nephrology and Urology
- Nuclear Medicine
- Orthopaedics
- Otorhinolaryngology
- Pathology (excl. Oral Pathology)
- Family Care